Creating what nature has not from AI and computational molec...
Kashif Sadiq, founder and CEO of DenovAI Biotech discusses harnessing the power of artificial intelligence and computational molecular biophysics.
Newsletters and Deep Dive digital magazine
Kashif Sadiq, founder and CEO of DenovAI Biotech discusses harnessing the power of artificial intelligence and computational molecular biophysics.
It goes without saying that healthcare is in the midst of a digital, AI-accelerated transformation.
Pharma companies are turning to digital opinion leaders (DOLs) to fight misconceptions, raise disease awareness, and promote their products.
Insilico has once again added to its roster of big pharma partners, signing a deal with Eli Lilly that includes a $115m upfront payment.
A machine learning algorithm could serve as a pre-screen for hepatocellular carcinoma that identifies patients missed by current narrow guidance.
Editor's Picks
Newsletters and Deep Dive
digital magazine